Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GLYCAR T cells |
Trade Name | |
Synonyms | GPC3 CAR T cells|CAR-GPC3 T Cells|Glypican-3 CAR T Cells |
Drug Descriptions |
GLYCAR T cells consist of a preparation of autologous peripheral blood mononuclear cells engineered to express a chimeric antigen receptor (CAR) targeting GPC3 linked to CD8 alpha hinge domain, CD28 transmembrane domain, and CD3zeta signaling domain, which may lead to antitumor activity, including reduced tumor growth in GPC3-positive tumor cells (PMID: 32371538). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C121638 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
GLYCAR T cells | GLYCAR T cells | 0 | 1 |
GLYCAR T cells + Sorafenib | GLYCAR T cells Sorafenib | 0 | 0 |